Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Select Medical Holdings (SEM) Depreciation & Amortization (IS) (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Depreciation & Amortization (IS) for 9 consecutive years, with $37.7 million as the latest value for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (IS) rose 8.21% year-over-year to $37.7 million; the TTM value through Mar 2026 reached $176.6 million, down 8.5%, while the annual FY2023 figure was $208.7 million, 1.42% up from the prior year.
  • Depreciation & Amortization (IS) hit $37.7 million in Q1 2026 for Select Medical Holdings, up from $34.8 million in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $54.1 million in Q1 2024 and bottomed at $34.8 million in Q1 2025.
  • Average Depreciation & Amortization (IS) over 5 years is $49.6 million, with a median of $51.5 million recorded in 2022.
  • Year-over-year, Depreciation & Amortization (IS) plummeted 35.62% in 2025 and then grew 8.21% in 2026.
  • Select Medical Holdings' Depreciation & Amortization (IS) stood at $52.2 million in 2022, then grew by 3.33% to $54.0 million in 2023, then dropped by 7.12% to $50.1 million in 2024, then tumbled by 30.58% to $34.8 million in 2025, then increased by 8.21% to $37.7 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (IS) over the past three periods came in at $37.7 million, $34.8 million, and $50.1 million for Q1 2026, Q1 2025, and Q3 2024 respectively.